Advanced solid tumors (other than Urothelial tumors), and FGFR gene research hub

A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations

This study is testing a new medicine, JNJ-42756493, for adults and children with advanced cancers that have a specific genetic change called an FGFR alteration. Researchers want to see if the medicine can shrink or make these cancers disappear.